Publicacions (48) Publicacions de RON GELLER -

2024

  1. An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins

    Scientific Reports, Vol. 14, Núm. 1

  2. Cell type-specific adaptation of the SARS-CoV-2 spike

    Virus Evolution, Vol. 10, Núm. 1

  3. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro

    PLoS ONE, Vol. 19, Núm. 2 February

  4. Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination

    Scientific reports, Vol. 14, Núm. 1, pp. 11896

  5. Mapping mutational fitness effects across the coxsackievirus B3 proteome reveals distinct profiles of mutation tolerability

    PLoS Biology, Vol. 22, Núm. 7 July

  6. Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity

    Plant Biotechnology Journal, Vol. 22, Núm. 4, pp. 876-891

  7. The Discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing

    Computers in Biology and Medicine, Vol. 171

2023

  1. A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population

    Journal of Medical Virology, Vol. 95, Núm. 4

  2. A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status

    Journal of Medical Virology, Vol. 95, Núm. 1

  3. Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals

    Journal of medical virology, Vol. 95, Núm. 7, pp. e28900

  4. Antigens from the Helminth Fasciola hepatica Exert Antiviral Effects against SARS-CoV-2 In Vitro

    International Journal of Molecular Sciences, Vol. 24, Núm. 14

  5. Aptamer-Capped Nanoporous Anodic Alumina for SARS-CoV-2 Spike Protein Detection

    Advanced Materials Technologies, Vol. 8, Núm. 11

  6. Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers

    iScience, Vol. 26, Núm. 6

  7. C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein

    Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457

  8. Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3

    Nature Communications, Vol. 14, Núm. 1

  9. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

  10. Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population

    The Journal of infection

2022

  1. Erratum: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation (PLoS Pathog (2022) 18:7 (e1010631) DOI: 10.1371/journal.ppat.1010631)

    PLoS Pathogens

  2. Identification of Cytoplasmic Chaperone Networks Relevant for Respiratory Syncytial Virus Replication

    Frontiers in Microbiology, Vol. 13

  3. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents

    Scientific reports, Vol. 12, Núm. 1, pp. 3788